Back to Search
Start Over
A survey of Australian general practitioners' hepatitis C knowledge and management 2 years after subsidised direct-acting antiviral therapy became available.
- Source :
- Sexual Health (14485028); 2020, Vol. 17 Issue 4, p387-389, 3p
- Publication Year :
- 2020
-
Abstract
- In 2016, hepatitis C direct-acting antivirals (DAAs) became available in Australia. A group of general practitioners (GPs) were surveyed twice to assess hepatitis C knowledge and management; 191/1000 (19.1%) responded at baseline, 164/938 (17.5%) at follow up. Participants' mean Knowledge score increased: baseline 5.75 (95% CI 5.61-5.91), follow up 6.09 (95% CI 5.95-6.22; P <0.01). At follow up, 36/163 (22%) had prescribed DAAs compared with 23/187 (12%) at baseline (χ2(1) = 5.95, P = 0.02); however, 67/150 (45%) were unsure of treatment eligibility for people who inject drugs. Additional support for GPs is warranted to ensure optimal hepatitis C management in primary care. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14485028
- Volume :
- 17
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Sexual Health (14485028)
- Publication Type :
- Academic Journal
- Accession number :
- 145386752
- Full Text :
- https://doi.org/10.1071/SH19189